Novavax Likely to Add Fourth COVID Vaccine to U.S. Arsenal

Novavax has announced that its coronavirus vaccine was 90.4 percent effective in a large clinical trial, potentially paving the way for its authorization for use in the U.S.

The vaccine showed levels of efficacy similar to the Pfizer-BioNTech and Moderna vaccines, following the trial involving 29,960 people in the U.S. and Mexico. Novavax’s vaccine uses proteins resembling the “spike” proteins on the surface of coronavirus, triggering an immune response in a recipient, in contrast to Pfizer and Moderna which use mRNA technology.

Novavax won a $1.6 billion contract for 100 million doses from the Trump administration’s Operation Warp Speed. The company has never produced a vaccine cleared by regulators in its 33-year history.

[link to www.nationalreview.com (secure)]



[link to www.youtube.com (secure)]

So wonderful! A 90% efficacy rate for a "disease" with a 99.9% survivability rate!

What is wrong with people if they cannot see there is a problem with the numbers?